Graeme Kerson
About Graeme Kerson
Graeme Kerson is a Clinical Program Manager at MeiraGTx in London, England, where he has worked since 2021. He has extensive experience in clinical study management, having held various roles at AbbVie, Allergan, Imperial College London, and Bayer HealthCare.
Work at MeiraGTx
Graeme Kerson has been serving as the Clinical Program Manager at MeiraGTx since 2021. In this role, he is responsible for overseeing clinical programs and ensuring the successful execution of clinical trials. His position is based in London, England, where he has contributed to the company's mission in gene therapy and innovative treatments.
Previous Experience in Clinical Program Management
Before joining MeiraGTx, Graeme Kerson held significant positions in clinical program management. He worked at AbbVie as Associate Director of Global Phase IV Study Management for 11 months in 2020-2021. Prior to that, he spent two years at Allergan in the same role, where he managed global Phase IV studies. His extensive experience in this field spans multiple organizations, highlighting his expertise in clinical trial management.
Educational Background in Biochemistry
Graeme Kerson earned a Bachelor of Science with Honours in Biochemistry from the University of Warwick. His studies took place from 1998 to 2001, providing him with a solid foundation in the biological sciences that supports his career in clinical program management.
Career Progression in Clinical Research
Graeme Kerson has a diverse background in clinical research, having worked in various roles over the years. He began his career as a Clinical Data Manager at Imperial College London from 2001 to 2003. He then progressed to positions such as Study Manager at Imperial College London and the Institute of Cancer Research. His tenure at Bayer HealthCare included roles as Head of Local Study Unit and Study Manager, further establishing his expertise in the field.